|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rampone B, Schiavone B, Martino A, Viviano
C and Confuorto G: Current management strategy of hepatocellular
carcinoma. World J Gastroenterol. 15:3210–3216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rahbari NN, Mehrabi A, Mollberg NM, Müller
SA, Koch M, Büchler MW and Weitz J: Hepatocellular carcinoma:
Current management and perspectives for the future. Ann Surg.
253:453–469. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu G, Qi FZ, Zhang JH, Cheng GF, Cai Y and
Miao Y: Meta-analysis of surgical resection and radiofrequency
ablation for early hepatocellular carcinoma. World J Surg Oncol.
10:1632012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
DuBray BJ Jr, Chapman WC and Anderson CD:
Hepatocellular carcinoma: A review of the surgical approaches to
management. Mo Med. 108:195–198. 2011.PubMed/NCBI
|
|
6
|
Salhab M and Canelo R: An overview of
evidence-based management of hepatocellular carcinoma: A
meta-analysis. J Cancer Res Ther. 7:463–475. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
De Minicis S, Candelaresi C, Marzioni M,
Saccomano S, Roskams T, Casini A, Risaliti A, Salzano R, Cautero N,
di Francesco F, et al: Role of endogenous opioids in modulating HSC
activity in vitro and liver fibrosis in vivo. Gut. 57:352–364.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peinado H, Alečković M, Lavotshkin S,
Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M,
Williams C, García-Santos G, Ghajar C, et al: Melanoma exosomes
educate bone marrow progenitor cells toward a pro-metastatic
phenotype through MET. Nat Med. 18:883–891. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kohno H, Sakai T, Saito S, Okano K and
Kitahara K: Treatment of experimental autoimmune uveoretinitis with
atorvastatin and lovastatin. Exp Eye Res. 84:569–576. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Byun MW: Schizonepeta tenuifolia ethanol
extract exerts anti-inflammatory activity through the inhibition of
TLR4 signaling in lipopolysaccharide-stimulated macrophage cells. J
Med Food. 17:350–356. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li J, Cheng Y, Qu W, Sun Y, Wang Z, Wang H
and Tian B: Fisetin, a dietary flavonoid, induces cell cycle arrest
and apoptosis through activation of p53 and inhibition of NF-kappa
B pathways in bladder cancer cells. Basic Clin Pharmacol Toxicol.
108:84–93. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ying TH, Yang SF, Tsai SJ, Hsieh SC, Huang
YC, Bau DT and Hsieh YH: Fisetin induces apoptosis in human
cervical cancer HeLa cells through ERK1/2-mediated activation of
caspase-8-/caspase-3-dependent pathway. Arch Toxicol. 86:263–273.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Contreras F, Fouillioux C, Bolívar A,
Simonovis N, Hernández-Hernández R, Armas-Hernandez MJ and Velasco
M: Dopamine, hypertension and obesity. J Hum Hypertens. 16 Suppl
1:S13–S17. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hazelwood LA, Free RB, Cabrera DM,
Skinbjerg M and Sibley DR: Reciprocal modulation of function
between the D1 and D2 dopamine receptors and the Na+,K+-ATPase. J
Biol Chem. 283:36441–36453. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Salyer S, Lesousky N, Weinman EJ, Clark
BJ, Lederer ED and Khundmiri SJ: Dopamine regulation of
Na+-K+-ATPase requires the PDZ-2 domain of sodium hydrogen
regulatory factor-1 (NHERF-1) in opossum kidney cells. Am J Physiol
Cell Physiol. 300:C425–C434. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang YR and Yuan ZY: Dopamine-mediated
inhibition of renal Na+/K+-ATPase in HK-2 cells is reduced by
ouabain. Clin Exp Pharmacol Physiol. 37:613–618. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Calarge CA, Ellingrod VL, Acion L, Miller
DD, Moline J, Tansey MJ and Schlechte JA: Variants of the dopamine
D2 receptor gene and risperidone-induced hyperprolactinemia in
children and adolescents. Pharmacogenet Genomics. 19:373–382. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Trussardi-Regnier A, Lavenus S, Gorisse MC
and Dufer J: Thalidomide alters nuclear architecture without ABCB1
gene modulation in drug-resistant myeloma cells. Int J Oncol.
35:641–647. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cagin YF, Parlakpinar H, Vardi N, Polat A,
Atayan Y, Erdogan MA and Tanbek K: Effects of dexpanthenol on
acetic acid-induced colitis in rats. Exp Ther Med. 12:2958–2964.
2016.PubMed/NCBI
|
|
20
|
Yang PM, Tseng HH, Peng CW, Chen WS and
Chiu SJ: Dietary flavonoid fisetin targets caspase-3-deficient
human breast cancer MCF-7 cells by induction of
caspase-7-associated apoptosis and inhibition of autophagy. Int J
Oncol. 40:469–478. 2012.PubMed/NCBI
|
|
21
|
Christiansen JJ and Rajasekaran AK:
Reassessing epithelial to mesenchymal transition as a prerequisite
for carcinoma invasion and metastasis. Cancer Res. 66:8319–8326.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Miyazono K, Ehata S and Koinuma D:
Tumor-promoting functions of transforming growth factor-β in
progression of cancer. Ups J Med Sci. 117:143–152. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wheelhouse NM, Lai PB, Wigmore SJ, Ross JA
and Harrison DJ: Mitochondrial D-loop mutations and deletion
profiles of cancerous and noncancerous liver tissue in hepatitis B
virus-infected liver. Br J Cancer. 92:1268–1272. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
van Zijl F, Zulehner G, Petz M, Schneller
D, Kornauth C, Hau M, Machat G, Grubinger M, Huber H and Mikulits
W: Epithelial-mesenchymal transition in hepatocellular carcinoma.
Future Oncol. 5:1169–1179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jin Z, McDonald ER III, Dicker DT and
El-Deiry WS: Deficient tumor necrosis factor-related
apoptosis-inducing ligand (TRAIL) death receptor transport to the
cell surface in human colon cancer cells selected for resistance to
TRAIL-induced apoptosis. J Biol Chem. 279:35829–35839. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim HS, Lee JW, Soung YH, Park WS, Kim SY,
Lee JH, Park JY, Cho YG, Kim CJ, Jeong SW, et al: Inactivating
mutations of caspase-8 gene in colorectal carcinomas.
Gastroenterology. 125:708–715. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang S, Ong CN and Shen HM: Involvement
of proapoptotic Bcl-2 family members in parthenolide-induced
mitochondrial dysfunction and apoptosis. Cancer Lett. 211:175–188.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pennarun B, Meijer A, De Vries EG,
Kleibeuker JH, Kruyt F and de Jong S: Playing the DISC: Turning on
TRAIL death receptor-mediated apoptosis in cancer. Biochim Biophys
Acta. 1805:123–140. 2010.PubMed/NCBI
|
|
29
|
Jung YH, Heo J, Lee YJ, Kwon TK and Kim
YH: Quercetin enhances TRAIL-induced apoptosis in prostate cancer
cells via increased protein stability of death receptor 5. Life
Sci. 86:351–357. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jia L and Zhang MH: Comparison of
probiotics and lactulose in the treatment of minimal hepatic
encephalopathy in rats. World J Gastroenterol. 11:908–911. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yamada M, Chiba T, Sasabe J, Nawa M,
Tajima H, Niikura T, Terashita K, Aiso S, Kita Y, Matsuoka M, et
al: Implanted cannula-mediated repetitive administration of
Abeta25-35 into the mouse cerebral ventricle effectively impairs
spatial working memory. Behav Brain Res. 164:139–146. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Seamans JK and Yang CR: The principal
features and mechanisms of dopamine modulation in the prefrontal
cortex. Prog Neurobiol. 74:1–58. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lu Q: Transforming growth factor-beta1
protects against pulmonary artery endothelial cell apoptosis via
ALK5. Am J Physiol Lung Cell Mol Physiol. 295:L123–L133. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Baarsma HA, Spanjer AI, Haitsma G,
Engelbertink LH, Meurs H, Jonker MR, Timens W, Postma DS, Kerstjens
HA and Gosens R: Activation of WNT/β-catenin signaling in pulmonary
fibroblasts by TGF-β1 is increased in chronic obstructive pulmonary
disease. PLoS One. 6:e254502011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu GL, Yang HJ, Liu T and Lin YZ:
Expression and significance of E-cadherin, N-cadherin, transforming
growth factor-β1 and Twist in prostate cancer. Asian Pac J Trop
Med. 7:76–82. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: New insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
